-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 20, Step Pharmaceuticals announced that Shaanxi Step Gao, a wholly-owned subsidiary, had recently received a "Drug Registration Certificate" for benzodiacycline chloride tablets approved by the State Drug Administration.
examination and approval shows that, in accordance with the Drug Administration Law of the People's Republic of China and the relevant provisions, after examination, the product meets the relevant requirements of drug registration, approves registration, and issues a drug registration certificate.
quality standards, instructions, packaging labels and production processes attached to the implementation.
is mainly suitable for hypertension, chronic stable angina, vasoconvulsive angina and coronary heart disease confirmed by angiocardiosis.
the original research manufacturer is Pfizer Pharmaceutical Co., Ltd.
according to Minenet data, the sales of sample hospitals from 2016 to 2019 were: 4.03 billion yuan, 4.352 billion yuan, 4.791 billion yuan and 4.762 billion yuan.
date of this announcement, Step Pharmaceuticals has invested approximately RMB8.94 million in research and development on ammonia chloride tablets.